Immunocal Clinical Research Initiative

Pharmaceutical Information

Author: Immunotec
Published: 2009/07/08 - Updated: 2023/08/06
Publication Type: Clinical Trial
Contents: Summary - Introduction - Main - Related

Synopsis: Immunotec receives authorization to begin a study on the effect of the cysteine-rich whey protein isolate in combination with physical exercise on muscle function, body composition and inflammatory cytokine levels in elderly persons: a randomized, double-blind study. Aging is typically associated with a decrease in skeletal muscle mass and muscle function, which contributes decisively to disability in old age and to a loss of quality of life The primary aim of this study is to determine whether taking a cysteine-rich whey protein isolate (IMMUNOCAL) compared to casein (a milk protein used as control, which contains little cysteine) may optimize the quality of life in the elderly.

Introduction

Immunotec receives NHPD/Health Canada authorization to begin a study on the effect of the cysteine-rich whey protein isolate (immunocal) in combination with physical exercise on muscle function, body composition and inflammatory cytokine levels in elderly persons: a randomized, double-blind study.

Main Digest

Immunotec Inc. has announced that the Natural Health Products Directorate (NHPD) - a division of Health Canada responsible for evaluating the safety, efficacy and quality of natural health products (NHPs) - granted authorization for Immunotec to conduct a clinical trial of IMMUNOCAL in elderly persons.

Aging is typically associated with a decrease in skeletal muscle mass and muscle function, which contributes decisively to disability in old age and to a loss of quality of life.

Proteins and Resistance Training

Resistance training exercise can increase muscle strength, function and mass in older adults.

The primary aim of this study is to determine whether taking a cysteine-rich whey protein isolate (IMMUNOCAL) compared to casein (a milk protein used as control, which contains little cysteine) may optimize the quality of life in the elderly.

The consumption of these proteins will be evaluated in association with resistance training to determine if the combination of Immunocal with exercise will provide significant gains in muscle strength, muscle mass and cognitive functions, compared to the same training program combined with taking casein, the control protein.

Benefits

Benefits in these fields can be translated to improved quality of life for elderly persons.

The Principal Investigator, Dr. Remi Rabasa-Lhoret, MD, PhD, Associate Research Professor and Metabolic Unit Laboratory Director, Institut de recherches cliniques de Montreal (IRCM) and his research team are very enthusiastic about the prospects of the trial.

Clinical Study

"Immunotec should be commended for initiating and supporting this very important research study of its lead product "Immunocal" in aging. It is rare to see companies in this field conducting double blind randomized studies with a control group. The focus of the study is highly relevant for people over the age of 65. Assessing the combined effects of exercise and supplementation with cysteine-rich whey protein isolate (IMMUNOCAL) as well as the potential impact on important functions, such as muscle strength and cognition may provide significant benefits," said Dr. Rabasa-Lhoret.

"NHPD, Health Canada's clearance of the clinical application for our Immunocal trial adds to our significant accomplishments and continued commitment in research," said Mr. James Northrop, President and CEO of Immunotec Inc.

"This marks the first, controlled clinical study of Immunocal in an elderly population. Furthermore, we are delighted with the fact that this study will be run at IRCM - a research center in the province of Quebec with an excellent reputation in Canada and internationally."

Attribution/Source(s):

This quality-reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Immunotec, and published on 2009/07/08 (Edit Update: 2023/08/06), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Immunotec can be contacted at immunotec.com. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Related Publications

Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): Immunotec. (2009, July 8 - Last revised: 2023, August 6). Immunocal Clinical Research Initiative. Disabled World. Retrieved July 24, 2024 from www.disabled-world.com/medical/pharmaceutical/immunocal-research.php

Permalink: <a href="https://www.disabled-world.com/medical/pharmaceutical/immunocal-research.php">Immunocal Clinical Research Initiative</a>: Immunotec receives authorization to begin a study on the effect of the cysteine-rich whey protein isolate in combination with physical exercise on muscle function, body composition and inflammatory cytokine levels in elderly persons: a randomized, double-blind study.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.